ISSN |
1949-8462 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Cardiac & Cardiovascular Systems |
Manuscript Type |
Retrospective Study |
Article Title |
Impact of gout on in-hospital outcomes of acute coronary syndrome-related hospitalizations and revascularizations: Insights from the national inpatient sample
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Rupak Desai, Tarang Parekh, Hemant Goyal, Hee Kong Fong, Dipen Zalavadia, Nanush Damarlapally, Rajkumar Doshi, Sejal Savani, Gautam Kumar and Rajesh Sachdeva |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Hemant Goyal, FACP, MBBS, MD, Assistant Professor, Department of Internal Medicine, Macon University School of Medicine, 707 Pine St., Macon, GA 31207, United States. doc.hemant@yahoo.com |
Key Words |
Gout; Serum uric acid; Acute coronary syndrome; Unstable angina; Myocardial infarction; Revascularization; Percutaneous coronary intervention; Coronary artery bypass grafting; In-hospital outcomes |
Core Tip |
Previous studies have established a role of gout in predicting risk and prognosis of cardiovascular diseases. However, large-scale data on the impact of gout on inpatient outcomes of acute coronary syndrome (ACS)-related hospitalizations and post-revascularization is inadequate. In this largest nationwide cohort, we identified 3144744 ACS-related hospitalizations, of which 105198 (3.35%) also had gout. Coronary artery bypass grafting was required more often in the ACS-gout cohort. Post-revascularization (percutaneous coronary intervention/coronary artery bypass grafting) complications including cardiovascular (3.2% vs 2.9%), respiratory (3.5% vs 2.9%), and hemorrhage (3.1% vs 2.7%) were higher and raised the mortality odds whereas all-cause mortality was lower (2.2% vs 3.0%) in the ACS-gout cohort. Mean length of stay, transfers and hospital charges were higher in the ACS-gout cohort. |
Publish Date |
2019-05-24 10:20 |
Citation |
Desai R, Parekh T, Goyal H, Fong HK, Zalavadia D, Damarlapally N, Doshi R, Savani S, Kumar G, Sachdeva R. Impact of gout on in-hospital outcomes of acute coronary syndrome-related hospitalizations and revascularizations: Insights from the national inpatient sample. World J Cardiol 2019; 11(5): 137-148 |
URL |
https://www.wjgnet.com/1949-8462/full/v11/i5/137.htm |
DOI |
https://dx.doi.org/10.4330/wjc.v11.i5.137 |